The price-to-earnings ratio for Doximity Inc (NYSE: DOCS) is above average at 63.28x. The 36-month beta value for DOCS is also noteworthy at 1.38. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 13 rating it as “hold,” and 0 rating it as “sell.”
The public float for DOCS is 123.70M, and at present, short sellers hold a 5.68% of that float. The average trading volume of DOCS on January 10, 2025 was 1.99M shares.
DOCS) stock’s latest price update
Doximity Inc (NYSE: DOCS) has seen a decline in its stock price by -0.87 in relation to its previous close of 55.48. However, the company has experienced a 3.02% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-01-07 that In December, we welcomed 29 new analysts to Seeking Alpha and in this article we are showcasing their stock picks and investment strategies. Five buy picks are highlighted on Viasat, Newmont, NeuroOne Medical, X-Fab Silicon Foundries, and ArcerlorMittal. Analysts’ recommendations range from Strong Buy to Strong Sell, covering diverse sectors such as healthcare, technology, energy, and consumer goods.
DOCS’s Market Performance
Doximity Inc (DOCS) has seen a 3.02% rise in stock performance for the week, with a -0.95% decline in the past month and a 24.04% surge in the past quarter. The volatility ratio for the week is 3.11%, and the volatility levels for the past 30 days are at 4.03% for DOCS. The simple moving average for the past 20 days is 0.38% for DOCS’s stock, with a 50.43% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with Stephens repeating the rating for DOCS by listing it as a “Equal-Weight.” The predicted price for DOCS in the upcoming period, according to Stephens is $55 based on the research report published on December 20, 2024 of the previous year 2024.
Mizuho, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $55. The rating they have provided for DOCS stocks is “Neutral” according to the report published on December 04th, 2024.
Goldman gave a rating of “Neutral” to DOCS, setting the target price at $58 in the report published on November 15th of the previous year.
DOCS Trading at 6.11% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.93% of loss for the given period.
Volatility was left at 4.03%, however, over the last 30 days, the volatility rate increased by 3.11%, as shares surge +2.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.33% upper at present.
During the last 5 trading sessions, DOCS rose by +3.02%, which changed the moving average for the period of 200-days by +98.99% in comparison to the 20-day moving average, which settled at $54.79. In addition, Doximity Inc saw 3.02% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from Bryson Anna, who sale 100,000 shares at the price of $58.42 back on Nov 12 ’24. After this action, Bryson Anna now owns 304,506 shares of Doximity Inc, valued at $5,842,248 using the latest closing price.
Bryson Anna, the Officer of Doximity Inc, proposed sale 70,000 shares at $60.00 during a trade that took place back on Nov 12 ’24, which means that Bryson Anna is holding shares at $4,200,000 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.39 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.34. The total capital return value is set at 0.2. Equity return is now at value 19.00, with 16.24 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 29.24.
Currently, EBITDA for the company is 182.08 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 19.54. The receivables turnover for the company is 4.14for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.21.
Conclusion
In summary, Doximity Inc (DOCS) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
